MRK - Merck mpany - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRK is currently covered by 20 analysts with an average price target of $102.73. This is a potential upside of $18.62 (22.14%) from yesterday's end of day stock price of $84.11.

Merck mpany's activity chart (see below) currently has 302 price targets and 328 ratings on display. The stock rating distribution of MRK is 80.23% BUY, 18.6% HOLD and 1.16% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.51% with an average time for these price targets to be met of 537.81 days.

Highest price target for MRK is $155, Lowest price target is $84, average price target is $121.91.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 10-Jul-2025. First documented stock forecast 29-Mar-2007.

Currently out of the existing stock ratings of MRK, 69 are a BUY (80.23%), 16 are a HOLD (18.6%), 1 are a SELL (1.16%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$98

$18.04 (22.56%)

$106

14 days ago
(10-Jul-2025)

14/19 (73.68%)

$13.98 (16.64%)

212

Buy

$84

$4.04 (5.05%)

$115

2 months 10 days ago
(14-May-2025)

14/18 (77.78%)

$10.53 (14.33%)

523

Buy

$84

$4.04 (5.05%)

$145

2 months 10 days ago
(14-May-2025)

8/9 (88.89%)

$10.53 (14.33%)

453

Buy

$115

$35.04 (43.82%)

$115

3 months 7 days ago
(17-Apr-2025)

2/4 (50%)

$37 (47.44%)

751

Buy

$100

$16.99 (20.47%)

$120

5 months 15 days ago
(10-Feb-2025)

2/3 (66.67%)

$12.72 (14.57%)

270

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRK (Merck mpany) average time for price targets to be met?

On average it took 537.81 days on average for the stock forecasts to be realized with a an average price target met ratio 80.51

Which analyst has the current highest performing score on MRK (Merck mpany) with a proven track record?

LOUISE CHEN

Which analyst has the most public recommendations on MRK (Merck mpany)?

Louise Chen works at SCOTIABANK and has 9 price targets and 5 ratings on MRK

Which analyst is the currently most bullish on MRK (Merck mpany)?

Louise Chen with highest potential upside - $75.04

Which analyst is the currently most reserved on MRK (Merck mpany)?

Marc Goodman with lowest potential downside - -$44.05

Merck mpany in the News

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

Company Logo Explore the evolving landscape of over 60 mRNA cancer vaccines progressing in clinical trials globally. Highlights include key biopharma collaborations, innovative proprietary technologies, competitive developments by region, and insights into leading candidates like Moderna and Merck’s mRNA-4157/V940. Dublin, July 07, 2025 (GLOBE NEWSWIRE) — The “mRNA Cancer Vaccines Clinical Trials, Market Trends By...

Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?